Primary adrenal failure and hypothyroidism adverse effect with nivolumab immuno‐oncology agent. JEMDSA Vol 23(3) 2019 Supp S144-145


GÜNEŞ E., CANDER S. , ÖZ GÜL Ö. , ERSOY C.

18th International Congress of Endocrinology, 53rd Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA) Congress, 1 - 04 December 2018

  • Publication Type: Conference Paper / Full Text